High flow nasal cannulae for respiratory support in adult intensive care patients
MetadataShow full item record
We will evaluate studies which include patients 16 years and over admitted to the ICU and who require treatment with HFNC. We will assess the safety and efficacy of HFNC compared with the comparator interventions in terms of failure of treatment, mortality, adverse events, duration of respiratory support, hospital and ICU length of stay, respiratory effects, patient reported outcomes, and cost of treatment.
Cochrane Database of Systematic Reviews
© 2012 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd. This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews, 2012, Issue 11. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.
Clinical Nursing: Secondary (Acute Care)